GE HealthCare Technologies (GEHC) earnings
In the quarter ended March 2026, GE HealthCare Technologies had revenue of $5.1B, up 7.4% on a year earlier, and diluted EPS of 0.85.
On July 29, 2026 it reported EPS of 1.13 against an estimate of 1.04 (beat).
The next report is expected on Wednesday, October 28, 2026 before the market opens, with EPS expected around 1.21.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Wed Oct 28, 2026 | Before open | 1.21 | — |
| Last | Wed Jul 29, 2026 | Before open | 1.04 | 1.13 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from GE HealthCare Technologies's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | $5.1B | +7.4% | 0.85 | -30.9% | 10.0% | 2026-04-29 |
| Dec 31, 2025 | $5.7B | +7.1% | — | — | 14.5% | 2026-02-04 |
| Sep 30, 2025 | $5.1B | +5.8% | 0.98 | -3.9% | 12.7% | 2025-10-29 |
| Jun 30, 2025 | $5.0B | +3.5% | 1.06 | +14.0% | 13.1% | 2025-07-30 |
| Mar 31, 2025 | $4.8B | +2.7% | 1.23 | +51.9% | 13.2% | 2025-04-30 |
| Dec 31, 2024 | $5.3B | +2.2% | — | — | 15.1% | 2025-02-13 |
| Sep 30, 2024 | $4.9B | +0.9% | 1.02 | +24.4% | 13.9% | 2024-10-30 |
| Jun 30, 2024 | $4.8B | +0.5% | 0.93 | +2.2% | 12.6% | 2024-07-31 |
| Mar 31, 2024 | $4.7B | -1.2% | 0.81 | +97.6% | 11.6% | 2024-04-30 |
| Dec 31, 2023 | $5.2B | +5.4% | — | — | 13.2% | 2024-02-06 |
| Sep 30, 2023 | $4.8B | +5.4% | 0.82 | -23.4% | 12.8% | 2023-10-31 |
| Jun 30, 2023 | $4.8B | +7.4% | 0.91 | -15.0% | 11.8% | 2023-07-25 |
Questions
When does GE HealthCare Technologies report earnings?
GE HealthCare Technologies's next earnings report is expected on October 28, 2026 before the market opens.
How did GE HealthCare Technologies do last quarter?
In the quarter ended March 2026, GE HealthCare Technologies had revenue of $5.1B, up 7.4% on a year earlier, and diluted EPS of 0.85.
From GE HealthCare Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.